We’ve seen an increasing number of headlines around the study and use of psychedelics like psilocybin, ketamine, MDMA and LSD. As research continues, many are wondering how these studies can be improved - and how they apply to work and leadership. 
In this episode, host Morra Aarons-Mele speaks with clinician Lebert Lester III of the Behavior Wellness Clinic about the application of psychedelics for depression or trauma, and how to increase the number of people of color in clinical trials for these types of medications. Then, she speaks with IMD professor Alyson Meister about her cutting edge research on psychedelics and leadership.
For Further Reading:
Could Psychedelics Open New Doors for Science and Business?